Calcitriol for postmenopausal osteoporosis

J. C. Gallagher, B. L. Riggs

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

Calcitriol has not been approved for the treatment of osteoporosis by the Food and Drug Administration. We do not claim that efficacy and safety have been demonstrated, but only that the findings are unclear enough to warrant continued investigation. For example, a recent two center, place-controlled study found that 3 years of treatment with calcitriol of women with postmenopausal osteoporosis resulted in a highly significant 65% reduction of vertebral fracture rate.

Original languageEnglish (US)
Number of pages1
JournalAnnals of internal medicine
Volume111
Issue number7
DOIs
StatePublished - Jan 1 1989

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this